The HEOR Associate Director is responsible for tactical execution of the evidence generation strategy across health economics and outcomes research disciplines in the Cardiovascular medical unit. This position is responsible for developing and executing Evidence Gen/Medical/HEOR project to support product value propositions that clearly establish: disease clinical and economic burden of illness; current treatment patterns and unmet medical and economic needs; product benefits on impacting unmet needs; and competitive differentiation. Additionally, the HEOR product lead will be responsible for leading and coordination cross-functional project teams including but not limited to medical affairs, real-world evidence, and external KOLs. Associate director will be directly responsible for: efficient project execution (on budget and on time) and high quality and impactful evidence (robust data, scientifically sound methods, and impactful communication of results), ensuring category data and evidence leadership by investigating and implementing robust data and evidence strategies (e.g. RWD, registries, patient surveys, provider surveys, tokenization, AI applications). The Associate Director will be a key member of the brand Evidence Generation/HEOR team ensuring close coordination with other team members.

The Associate Director will serve as a key contributor, as needed, to the primary strategic teams (Medical strategy team, Integrated Product Strategy team, etc.). They will need to demonstrate strong leadership and strategic thinking in the areas of HEOR, clinical, commercial and ability to manage multiple projects. The Associate Director will also communication of impact of evidence findings both externally (manuscripts/posters, conferences) and internally (MSL training, medical affairs, commercial teams (as appropriate).

Key Responsibilities:

• Proactively generate and communicate evidence necessary to optimize patient access, inform physician practice, and value of Novartis products in the US market. Efficient project tactical execution.
• Manage multiple HEOR projects, associated budgets and external & internal partners, while ensuring a high level of scientific rigor and alignment with stakeholders.
• Support Director/Senior Director HEOR/Ev Gen team lead in the development of medical and Evidence/HEOR strategies to demonstrate the value of products to payers, clinical decision-makers, and patients.
• Exhibit medical leadership in strategic alignment with other areas and proactively propose new impactful ideas in cross-functional teams.
• Build robust external KOL, institutional and individual level partnerships as needed.
• Effectively communicate impactful research to diverse audiences.
• Publish and present impactful research at scientific conferences and forums.

Essential Requirements:

• Minimum 3-years’ experience in the pharma or healthcare sector, preferably in health economics, market access or related functions/fields is required.
• Substantial experience across all data verticals (real-world data, randomized controlled trials, surveys, registries, tokenization), methodological techniques (retrospective/prospective AI, frequentist, Bayesian methods) in support of products across the life-cycle (inline, launch and pipeline).
• Strong publication record
• Experience engaging or partnering with external organizations (e.g., SOCs, payers, universities, value assessors, regulatory agencies, etc.) is strongly preferred.
• Candidates for AD have consistently demonstrated ability to lead and execute complicated cross-functional project teams both within their direct area of responsibility and across their organization,

• Expert knowledge of Health Economics, Outcomes Research, and Real World Evidence including study design, methodologies, modeling, data sources and analyses is required.
• Deep knowledge of US healthcare financing and delivery system, US payer environment, evolving trends and competitive landscape is required.

Education:

• An advanced degree (masters or doctorate) in health economics, statistics, epidemiology, health policy or related field is required.
• PhD or PharmD with strong focus in Health Economics, Public Health, Epidemiology or related field preferred.

Novartis Compensation and Benefit Summary:

The pay range for this position at commencement of employment is expected to be between $168,000.00 and $312,000.00 per year; however, while salary ranges are effective from 1/1/24 through 12/31/24, fluctuations in the job market may necessitate adjustments to pay ranges during this period. Further, final pay determinations will depend on various factors, including, but not limited to geographical location, experience level, knowledge, skills and abilities. The total compensation package for this position may also include other elements, including a sign-on bonus, restricted stock units, and discretionary awards in addition to a full range of medical, financial, and/or other benefits (including 401(k) eligibility and various paid time off benefits, such as vacation, sick time, and parental leave), dependent on the position offered. Details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.